Literature DB >> 16629848

Introduction: Apolipoproteins and guidelines for prevention of cardiovascular disease.

O Faergeman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16629848     DOI： 10.1111/j.1365-2796.2006.01650.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN： 0954-6820            Impact factor:   8.989


× No keyword cloud information.
  4 in total

1.  New Zealand cardiovascular guidelines: best practice evidence-based guideline: the assessment and management of cardiovascular risk December 2003.

Authors:  Michael Crooke
Journal:  Clin Biochem Rev       Date:  2007-02

2.  Predictive value of serum apolipoprotein B/apolipoprotein A-I ratio in metabolic syndrome risk: a Chinese cohort study.

Authors:  Yu-Ching Chou; Jen-Chun Kuan; Chyi-Huey Bai; Tsan Yang; Wan-Yun Chou; Po-Chien Hsieh; San-Lin You; Lee-Ching Hwang; Chien-Hua Chen; Cheng-Yu Wei; Chien-An Sun
Journal:  Endocrine       Date:  2014-10-12       Impact factor: 3.633

3.  The association between the apolipoprotein B/A-I ratio and coronary calcification may differ depending on kidney function in a healthy population.

Authors:  Seok-Hyung Kim; Donghwan Oh; Kwon Soo Jung; Jung Eun Lee; Hyunwook Kim; Hyung Jong Kim; Beom Seok Kim; Hyeong Cheon Park; Byoung Kwon Lee; Hoon Young Choi
Journal:  PLoS One       Date:  2017-09-28       Impact factor: 3.240

4.  ApoB/apoA1 is an effective predictor of coronary heart disease risk in overweight and obesity.

Authors:  Min Lu; Qun Lu; Yong Zhang; Gang Tian
Journal:  J Biomed Res       Date:  2011-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.